Biofrontera Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2021. For the fourth quarter of 2021, revenue is anticipated to be in the range of approximately $9.1 million to $9.2 million, an increase of approximately 7% over the same quarter last year.

For the full year 2021, revenue is anticipated to be in the range of $24.1 million to $24.2 million, an increase of approximately 27% over full year 2020.